Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.
Thanks!

Click here for a guide on disabling your adblocker.

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

US (MA): Freetown-based cannabis center completes first harvest

AmeriCann, a cannabis company that is developing state-of-the-art cultivation, processing and product manufacturing facilities, announced the first harvest at its new state-of-the-art cannabis cultivation and processing facility.

AmeriCann’s Joint Venture partner recently commenced operations at AmeriCann’s Massachusetts Cannabis Center (“MCC”) in Freetown, MA. The initial phase of the development, Building 1, is a 30,000 square foot cultivation greenhouse and processing facility, 100 percent of which is occupied by Bask, Inc., an existing Massachusetts licensed vertically integrated cannabis operator.

Bask completed its initial cannabis harvest at Building 1 and is ramping up production to meet the growing needs in Massachusetts. Building 1 is an operating, licensed medical cannabis cultivation and processing facility, which supports Bask’s medical dispensary, home delivery service, and wholesale partners.

“We are proud that we have been able to deliver this advanced, sustainable cultivation facility at this important time,” stated AmeriCann CEO Tim Keogh. “Medical cannabis has been designated an essential business in Massachusetts and the initial building at our Massachusetts Cannabis Center is serving an important role in the supply chain of medicine for The Commonwealth.”

Massachusetts has implemented a “Stay at Home Advisory” in response to the COVID- 19 pandemic. Massachusetts Governor Baker deemed medical cannabis businesses as an essential service and encouraged medical cannabis businesses to continue to operate during this advisory.

To ensure business continuity and the safety of its patients and employees, AmeriCann and Bask have proactively adopted operational improvements based on guidance from the Center for Disease Control, the Cannabis Control Commission and other agencies from the Commonwealth.



During the 15-year Joint Venture for Building 1, AmeriCann will receive Base Rent and a Revenue Participation Fee from Bask of 15% of all gross monthly sales of cannabis, cannabis-infused products and non-cannabis products produced. Annually, the facility is projected to produce 7,500 pounds of dry flower cannabis and over 400,000 units of infused product.

The Massachusetts cannabis market has some of the highest cannabis prices in the United States, with wholesale prices exceeding $4,000 per pound and retail prices greater than $8,000 per pound.

The Massachusetts Cannabis Center is being developed on a 52-acre parcel located in Southeastern Massachusetts. The MCC project is permitted for 987,000 sq. ft. of cannabis cultivation and processing infrastructure, which will be developed in phases, and plans to support both the existing medical cannabis and the adult-use cannabis markets.

For more information:
AmeriCann
3200 Brighton Blvd. Unit 114
Denver, CO 80216
(303) 862-9000
info@americann.co  
americann.co   

Publication date: